- Filed
- Feb 20, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Feb 16, 2024 | 32.63M sh |
| Shares Diluted | Q3 2024 · Dec 31, 2023 | 4.39M sh |
| Shares Diluted | Q3 2024 · Dec 31, 2023 | 2.85M sh |
| Shares Diluted restated | Q3 2024 · Dec 31, 2022 | 950K sh |
| Shares Diluted restated | Q3 2024 · Dec 31, 2022 | 912.32K sh |
| Capex | Q3 2024 · Dec 31, 2023 | $72.05K |
| Operating Cash Flow | Q3 2024 · Dec 31, 2023 | −$20.56M |
| Operating Cash Flow restated | Q3 2024 · Dec 31, 2022 | −$12.39M |
| Long Term Debt | Q3 2024 · Dec 31, 2023 | $132.34K |
| Long Term Debt | Q3 2024 · Mar 31, 2023 | $149.72K |
| Short Term Debt | Q3 2024 · Dec 31, 2023 | $313.86K |
| Short Term Debt | Q3 2024 · Mar 31, 2023 | $311.54K |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $101.49K |
| Cash And Equivalents | Q3 2024 · Mar 31, 2023 | $65.84K |
| Stockholders Equity | Q3 2024 · Dec 31, 2023 | −$8M |
| Stockholders Equity | Q3 2024 · Mar 31, 2023 | −$9.61M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $29.06M |
| Current Liabilities | Q3 2024 · Mar 31, 2023 | $37.19M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $30.52M |
| Total Liabilities | Q3 2024 · Mar 31, 2023 | $37.72M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $9.83M |
| Current Assets | Q3 2024 · Mar 31, 2023 | $11.82M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $16.96M |
| Total Assets | Q3 2024 · Mar 31, 2023 | $23.78M |
| Eps Diluted | Q3 2024 · Dec 31, 2023 | −$3.37 |
| Eps Diluted | Q3 2024 · Dec 31, 2023 | −$8.62 |
| Eps Diluted restated | Q3 2024 · Dec 31, 2022 | $2.55 |
| Eps Diluted restated | Q3 2024 · Dec 31, 2022 | −$36.21 |
| Eps Basic | Q3 2024 · Dec 31, 2023 | −$3.37 |
| Eps Basic | Q3 2024 · Dec 31, 2023 | −$8.62 |
| Eps Basic restated | Q3 2024 · Dec 31, 2022 | $2.55 |
| Eps Basic restated | Q3 2024 · Dec 31, 2022 | −$36.21 |
| Sga Expense | Q3 2024 · Dec 31, 2023 | $6.9M |
| Sga Expense | Q3 2024 · Dec 31, 2023 | $23.18M |
| Sga Expense restated | Q3 2024 · Dec 31, 2022 | $1.09M |
| Sga Expense restated | Q3 2024 · Dec 31, 2022 | $2.39M |
| Net Income | Q3 2024 · Dec 31, 2023 | −$14.8M |
| Net Income | Q3 2024 · Dec 31, 2023 | −$23.37M |
| Net Income | Q3 2024 · Dec 31, 2022 | $2.75M |
| Net Income restated | Q3 2024 · Dec 31, 2022 | −$30.39M |
| Operating Income | Q3 2024 · Dec 31, 2023 | −$10.24M |
| Operating Income | Q3 2024 · Dec 31, 2023 | −$28.67M |
| Operating Income restated | Q3 2024 · Dec 31, 2022 | −$1.45M |
| Operating Income restated | Q3 2024 · Dec 31, 2022 | −$3.55M |
| Gross Profit | Q3 2024 · Dec 31, 2023 | −$1.82M |
| Gross Profit | Q3 2024 · Dec 31, 2023 | −$1.87M |
| Cost Of Revenue | Q3 2024 · Dec 31, 2023 | $2.06M |
| Cost Of Revenue | Q3 2024 · Dec 31, 2023 | $2.17M |
| Revenue | Q3 2024 · Dec 31, 2023 | $64.35K |